Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 40.68
-2.26 (-5.26%)
Oct 21, 2026, 1:48 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 7.94 billion as of October 20, 2026. It is the 9,877th most valuable company in the world and the 496th biggest in Hong Kong. Its market cap has decreased by 40.43% in one year.
Market Cap
7.94B
Enterprise Value
6.93B
Revenue
246.16M
Global Rank
Country Rank
#496 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 7.94B, a decrease of -38.82%. That is a compound annual growth rate of -32.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 8.06B | -20.55% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 11.88B |
| Ascentage Pharma Group International | 11.24B |
| GenFleet Therapeutics (Shanghai) | 11.00B |
| Suzhou Ribo Life Science | 8.91B |
| HBM Holdings | 8.64B |
| CStone Pharmaceuticals | 8.09B |
| Shanghai Haohai Biological Technology | 7.27B |
| Lepu Biopharma | 7.01B |